The University of Texas MD Anderson Cancer Center and Myriad Genetics, Inc. today announced a five-year strategic alliance to accelerate the clinical evaluation and development of Myriad’s molecular residual disease (MRD) assay.
Report: The State of AI During the Great Burnout in Healthcare
What You Should Know: – Innovaccer Inc., a healthcare AI company, has released a new research report, “The State of AI During the Great Burnout